SCHEMBL2561990

SCHEMBL2561990

CCCn1nnnc1S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5154397 0.87 HTT (0.45)
SCHEMBL1251275 0.85 SLC9A1 (0.42)
SCHEMBL11227578 0.85 CYP1A2 (0.38)
SCHEMBL8004195 0.84 SLC9A1 (0.44)
SCHEMBL10601434 0.84 SLC9A1 (0.44)
SCHEMBL7092801 0.84 SLC9A1 (0.44)
SCHEMBL10601672 0.84 SLC9A1 (0.44)
SCHEMBL6536864 0.84 SLC9A1 (0.44)
SCHEMBL6241128 0.84 SLC9A1 (0.44)
SCHEMBL8062094 0.84 SLC9A1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6602655-B2 Stability; compatibility; mixture with antifogging agent EASTMAN KODAK COMPANY 2003-08-05 US claimed
US-20020168597-A1 Black-and-white developing compositions and methods of use CARESTREAM HEALTH, INC. 2002-11-14 US claimed
US-20020146652-A1 For use in processing silver halide materials, and particularly radiographic materials EASTMAN KODAK COMPANY 2002-10-10 US claimed
US-20170073359-A1 Optically-Detectable Enzyme Substrates and Their Method of Use MOLECULAR PROBES, INC. 2017-03-16 US disclosed
WO-2011122815-A2 NOVEL QUINOXALINE DERIVATIVES DONG-A PHARM.CO.,LTD. (KR) 2011-10-06 WO disclosed
US-6602655-B2 Stability; compatibility; mixture with antifogging agent EASTMAN KODAK COMPANY 2003-08-05 US disclosed
EP-0745894-B1 Black and white photographic elements containing release compounds and method of preparing photographic emulsion EASTMAN KODAK CO (US) 2003-01-22 EP disclosed
US-20020168597-A1 Black-and-white developing compositions and methods of use CARESTREAM HEALTH, INC. 2002-11-14 US disclosed
US-20020146652-A1 For use in processing silver halide materials, and particularly radiographic materials EASTMAN KODAK COMPANY 2002-10-10 US disclosed
EP-1227366-A1 Black-and-white developing compositions and methods of use EASTMAN KODAK COMPANY (US) 2002-07-31 EP disclosed
US-6376164-B1 CONTAINING 2-THIOBENZOTHIAZOLE COMPOUND FUJI PHOTO FILM CO., LTD. (JP) 2002-04-23 US disclosed
US-4737442-A INCLUDING A SENSITIZER AND A BLOCKED DEVELOPMENT RESTRAINER; FREE OF BLACK SPOTS FUJI PHOTO FILM CO., LTD. (JP) 1988-04-12 US disclosed
CN-86108176-A Lankacidin derivatives and process for producing the same 1987-10-21 CN disclosed
US-4643991-A TREATMENT OF EMPHYSEMA THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 1987-02-17 US disclosed
US-4493833-A BACTERICIDES, ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-01-15 US disclosed
US-4304770-A Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-12-08 US disclosed
US-4110338-A Product and preparation of 1H-tetrazole-5-thiol derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1978-08-29 US disclosed
US-3994887-A ANTIBACTERIAL RECHERCHE ET INDUSTRIE THERAPEUTIQUES (R.I.T.) (BE) 1976-11-30 US disclosed
US-3968226-A 3-Heterocyclic thiomethylcephalosporins as antibacterial agents SMITHKLINE CORPORATION (US) 1976-07-06 US disclosed
US-3962232-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1976-06-08 US disclosed